Legend Biotech Announces Participation in Upcoming Investor Conferences

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced it will participate in the upcoming investor conferences:

Event: Jefferies Healthcare Conference Location: New York, NY Fireside Chat Date & Time: Wednesday, June 7, 2023 at 1:30pm ET Presenter: Ying Huang, Ph.D., CEO

Event: Goldman Sachs 44th Annual Global Healthcare Conference Location: Dana Point, CA Fireside Chat Date & Time: Wednesday, June 14, 2023 at 8:00am PT Presenter: Ying Huang, Ph.D., CEO

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230602005227/en/

Investor Contacts: Joanne Choi, Senior Manager, Investor Relations, Legend Biotech [e-mail]

Crystal Chen, Manager, Investor Relations, Legend Biotech [e-mail]

Press Contact: Tina Carter, Corporate Communications Lead, Legend Biotech [e-mail] [phone]